Cargando…
Evaluating glucose‐lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial
Understanding the benefits and risks of treatments to be used by older individuals (≥65 years old) is critical for informed therapeutic decisions. Glucose‐lowering therapy for older patients with diabetes should be tailored to suit their clinical condition, comorbidities and impaired functional stat...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383926/ https://www.ncbi.nlm.nih.gov/pubmed/32100382 http://dx.doi.org/10.1111/dom.14013 |